Abstract:Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the central nervous system (CNS). CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for neurodegenerative disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance (i) in CSF, (ii) in short post-mortem interval brain tissue-derived extracellular fluid (ECF) and (iii) in brain tissue biopsy derived from Alzheimer's disease (AD) or age-matched control neocortex and/or hippocampal CA1. 3'-untranslated region (3'-UTR) sequence/vector analysis; Aβ42-peptide+TNFα-induced and/or hydrogen peroxide-induced stress; bioinformatics; CAPE, CAY10512, DNA array; DNA/RNA sequencing; human brain biopsy/postmortem tissue; human CSF;LED-Northern micro-dot blot analysis; micro-RNA array; protected anti-miRNAs; RT-PCR; statistical analysis, β-actin, TREM-2- and CFH-3'-UTR-luciferase-reporter transfection assay; UV/fluorescent microscopy; Western immuno-histochemistry. There was a trend for decreased-abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean-age ∼72 yr; N=12; p∼0.06, ANOVA). The most abundant nucleic acids in AD-CSF and ECF were miRNAs and their speciation, abundance and inducibility were studied further. Comparison of miRNA signals between biopsy and post-mortem tissues (0.5–6 hrs) indicated a short half-life for many brain-enriched miRNAs. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155. Increases in miRNAs were confirmed independently using a highly-sensitive LED-Northern dot-blot assay. Primary human neuronal-glial cell co-cultures stressed with AD-derived ECF, TNFα or peroxide also displayed an up-regulation of these and other miRNAs. These effects were quenched using the anti-NF-КB agents caffeic acid-phenethyl-ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). The results indicate that miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155 are a family of inducible, NF-КB-sensitive pro-inflammatory miRNAs that are abundant in AD tissues and fluids. These AD-upregulated miRNAs further associate with deficits in the innate-immune response and the chronic and progressive spreading of inflammatory neurodegeneration. Enrichment of these miRNAs in circulating CSF and ECF suggest that they may be involved in the proliferation of miRNA-triggered pathogenic signaling throughout the AD brain and CNS.

microRNA‐425 loss mediates amyloid plaque microenvironment heterogeneity and promotes neurodegenerative pathologies

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Exosomes Mediate APP Dysregulation <i>via</i> APP-miR-185-5p Axis

Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice.

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

MicroRNAs: Pioneering Regulators in Alzheimer’s Disease Pathogenesis, Diagnosis, and Therapy

A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

The Protective Role of microRNA-200c in Alzheimer's Disease Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum Stress

Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis

MicroRNA Complexity in Alzheimer's Disease Cerebrospinal Fluid, Extracellular Fluid and Brain Tissue Biopsy

MicroRNAs 99B-5P/100-5p Regulated by Endoplasmic Reticulum Stress Are Involved in Abeta-Induced Pathologies.

Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's disease.

MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease

Role of miR-211 in Neuronal Differentiation and Viability: Implications to Pathogenesis of Alzheimer's Disease.

miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer’s disease

O3‐01‐05: MIR‐204 ATTENUATES MEMORY DEFICITS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

MicroRNA-144 is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related A Disintegrin and Metalloprotease 10 (ADAM10)